Spectrum Pharmacy Products Announces a Proactive Approach to the Prevention of Melamine Contamination

Share Article

Spectrum Pharmacy Products announced that they are fully committed to ensuring that every one of their products that contains, or is produced, using one of the pharmaceutical components identified by the U.S. FDA Center for Veterinary Medicine (CVM), a part of FDA's Center for Drug Evaluation and Research (CDER), is free from melamine contamination. Spectrum has developed a proactive approach to the prevention of melamine contamination by documenting the source of all raw materials utilized in the manufacturing process, the assessment of the manufacturing process itself, and the evaluation of other potential sources of melamine contamination of such at-risk products.

Spectrum Pharmacy Products

Spectrum Pharmacy Products remains steadfast in our resolve to safeguard our customers, and the downstream public, from melamine contamination and will continue to offer additional melamine certifications as they become available

Spectrum Pharmacy Products (http://www.SpectrumRx.com ) has re-affirmed their full commitment in ensuring that all the pharmaceutical components they provide are wholesome and contaminant free. In August 2009, the U.S. FDA Center for Veterinary Medicine (CVM), a part of FDA's Center for Drug Evaluation and Research (CDER), published a Guidance for Industry, titled,] Pharmaceutical Components at Risk for Melamine Contamination.

Building upon the CVM Guidance, Spectrum has developed its own proactive approach to the prevention of melamine contamination. This approach begins with assuring the integrity of their starting materials. Spectrum has been diligently working with their manufacturing partners and suppliers to address this concern and to extend their melamine-specific quality assurance measures as far upstream as possible in the supply chain. They have been able to do this by documenting the source of all raw materials utilized in the manufacturing process, the assessment of the manufacturing process itself, and the evaluation of other potential sources of melamine contamination of such at-risk products.

Additional tests are being developed by Spectrum's Quality Control Laboratories to provide further assurance that all of Spectrum's products remain free from melamine contamination.

To help their customers formally document the integrity of the materials obtained from Spectrum, product-specific melamine certificates can easily be obtained on the Spectrum website (http://www.SpectrumRx.com ).

"Spectrum Pharmacy Products remains steadfast in our resolve to safeguard our customers, and the downstream public, from melamine contamination and will continue to offer additional melamine certifications as they become available", says Tom Tyner, Spectrum's VP Quality Control.

About Spectrum Pharmacy Products

Founded in 1971, Spectrum Pharmacy Products, a division of Spectrum Chemical Mfg. Corp., manufactures and distributes compounding ingredients and laboratory products with quality and delivery you can count on every time. Spectrum's compounding offerings include more than 1,100 USP/NF and FCC ingredients and nearly 17,000 supply and equipment products from over 200 manufacturers such as; Mettler-Toledo, Ohaus, Corning, Denver Instrument, Exakt, Jencons, IKA, Hirschmann, Microflex, Dyn-A-Med, Thermo Scientific, Wheaton, Kimble Chase and Health Engineering Systems. Spectrum's ISO 9001:2000 certified facilities are FDA registered and operate under current Good Manufacturing Practices (cGMP). To learn more about Spectrum Pharmacy Products, please visit http://www.SpectrumRx.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kelly Blachford
Visit website